Graft failure following reduced‐intensity cord blood transplantation for adult patients

Summary We reviewed the medical records of 123 adult reduced‐intensity cord blood transplantation (RI‐CBT) recipients to investigate the clinical features of graft failure after RI‐CBT. Nine (7·3%) had graft failure, and were classified as graft rejection rather than primary graft failure; they show...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2006-01, Vol.132 (1), p.36-41
Hauptverfasser: Narimatsu, Hiroto, Kami, Masahiro, Miyakoshi, Shigesaburo, Murashige, Naoko, Yuji, Koichiro, Hamaki, Tamae, Masuoka, Kazuhiro, Kusumi, Eiji, Kishi, Yukiko, Matsumura, Tomoko, Wake, Atsushi, Morinaga, Shinichi, Kanda, Yoshinobu, Taniguchi, Shuichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 41
container_issue 1
container_start_page 36
container_title British journal of haematology
container_volume 132
creator Narimatsu, Hiroto
Kami, Masahiro
Miyakoshi, Shigesaburo
Murashige, Naoko
Yuji, Koichiro
Hamaki, Tamae
Masuoka, Kazuhiro
Kusumi, Eiji
Kishi, Yukiko
Matsumura, Tomoko
Wake, Atsushi
Morinaga, Shinichi
Kanda, Yoshinobu
Taniguchi, Shuichi
description Summary We reviewed the medical records of 123 adult reduced‐intensity cord blood transplantation (RI‐CBT) recipients to investigate the clinical features of graft failure after RI‐CBT. Nine (7·3%) had graft failure, and were classified as graft rejection rather than primary graft failure; they showed peripheral cytopenia with complete loss of donor‐type haematopoiesis, implying destruction of donor cells by immunological mechanisms rather than poor graft function. Three of them died of bacterial or fungal infection during neutropenia. Two recovered autologous haematopoiesis. The remaining four patients underwent a second RI‐CBT and developed severe regimen‐related toxicities. One died of pneumonia on day 8, and the other three achieved engraftment. Two of them died of transplant‐related mortality, and the other survived without disease progression for 9·0 months after the second RI‐CBT. In total, seven of the nine patients with graft failure died. The median survival of those with graft failure was 3·8 months (range, 0·9–15·4). Graft failure is a serious complication of RI‐CBT. As host T cells cannot completely be eliminated by reduced‐intensity preparative regimens, we need to be aware of the difficulty in differentiating graft rejection from other causes of graft failure following RI‐CBT. Further studies are warranted to establish optimal diagnostic and treatment strategies.
doi_str_mv 10.1111/j.1365-2141.2005.05832.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_198501548</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>943886951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5402-baebbe53d6d4355416453a7ecdd76a76cc756bdef23b39bbce141cec03db80ac3</originalsourceid><addsrcrecordid>eNqNkL1u2zAURokiReOmfYWACJBRyqVISvKQITESJ0WALu3QieCfChm06JAUYm95hD5jn6RUbMRr78IL8nyX5EEIEyhJrqtVSWjNi4owUlYAvATe0qrcfkCz94MTNAOApiDA2lP0OcYVAKHAySd0SmraECDtDP1aBtkl3MnejcHizjvnX_rhNw7WjNqav69_-iHZIfZph7UPBivnvcEpyCFunBySTL0fcjBgaUaX8CZv2CHFL-hjJ120Xw_rGfp5f_dj8VA8fV8-Lm6eCs0ZVIWSVinLqakNo5wzUjNOZWO1MU0tm1rrhtfK2K6iis6V0jb_TVsN1KgWpKZn6GI_dxP882hjEis_hiFfKci85UA4azPU7iEdfIzBdmIT-rUMO0FATErFSkzmxGROTErFm1KxzdHzw_xRra05Bg8OM3B5AGTU0nXZjO7jkWtYU88Zy9z1nnvpnd399wPE7beHqaP_ANANlK8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198501548</pqid></control><display><type>article</type><title>Graft failure following reduced‐intensity cord blood transplantation for adult patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><creator>Narimatsu, Hiroto ; Kami, Masahiro ; Miyakoshi, Shigesaburo ; Murashige, Naoko ; Yuji, Koichiro ; Hamaki, Tamae ; Masuoka, Kazuhiro ; Kusumi, Eiji ; Kishi, Yukiko ; Matsumura, Tomoko ; Wake, Atsushi ; Morinaga, Shinichi ; Kanda, Yoshinobu ; Taniguchi, Shuichi</creator><creatorcontrib>Narimatsu, Hiroto ; Kami, Masahiro ; Miyakoshi, Shigesaburo ; Murashige, Naoko ; Yuji, Koichiro ; Hamaki, Tamae ; Masuoka, Kazuhiro ; Kusumi, Eiji ; Kishi, Yukiko ; Matsumura, Tomoko ; Wake, Atsushi ; Morinaga, Shinichi ; Kanda, Yoshinobu ; Taniguchi, Shuichi</creatorcontrib><description>Summary We reviewed the medical records of 123 adult reduced‐intensity cord blood transplantation (RI‐CBT) recipients to investigate the clinical features of graft failure after RI‐CBT. Nine (7·3%) had graft failure, and were classified as graft rejection rather than primary graft failure; they showed peripheral cytopenia with complete loss of donor‐type haematopoiesis, implying destruction of donor cells by immunological mechanisms rather than poor graft function. Three of them died of bacterial or fungal infection during neutropenia. Two recovered autologous haematopoiesis. The remaining four patients underwent a second RI‐CBT and developed severe regimen‐related toxicities. One died of pneumonia on day 8, and the other three achieved engraftment. Two of them died of transplant‐related mortality, and the other survived without disease progression for 9·0 months after the second RI‐CBT. In total, seven of the nine patients with graft failure died. The median survival of those with graft failure was 3·8 months (range, 0·9–15·4). Graft failure is a serious complication of RI‐CBT. As host T cells cannot completely be eliminated by reduced‐intensity preparative regimens, we need to be aware of the difficulty in differentiating graft rejection from other causes of graft failure following RI‐CBT. Further studies are warranted to establish optimal diagnostic and treatment strategies.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2005.05832.x</identifier><identifier>PMID: 16371018</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; chimaerism ; Cord Blood Stem Cell Transplantation - methods ; Female ; graft failure ; Graft Rejection ; Graft Survival ; Graft vs Host Disease - diagnosis ; graft‐versus‐host disease ; Hematologic and hematopoietic diseases ; Hematologic Neoplasms - complications ; Hematologic Neoplasms - therapy ; Hematology ; Histocompatibility Testing ; Humans ; Male ; Medical sciences ; Middle Aged ; Neutropenia - complications ; Opportunistic Infections - complications ; second transplantation ; Treatment Outcome</subject><ispartof>British journal of haematology, 2006-01, Vol.132 (1), p.36-41</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Blackwell Publishing Jan 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5402-baebbe53d6d4355416453a7ecdd76a76cc756bdef23b39bbce141cec03db80ac3</citedby><cites>FETCH-LOGICAL-c5402-baebbe53d6d4355416453a7ecdd76a76cc756bdef23b39bbce141cec03db80ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2005.05832.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2005.05832.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,1435,27933,27934,45583,45584,46418,46842</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17476944$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16371018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Narimatsu, Hiroto</creatorcontrib><creatorcontrib>Kami, Masahiro</creatorcontrib><creatorcontrib>Miyakoshi, Shigesaburo</creatorcontrib><creatorcontrib>Murashige, Naoko</creatorcontrib><creatorcontrib>Yuji, Koichiro</creatorcontrib><creatorcontrib>Hamaki, Tamae</creatorcontrib><creatorcontrib>Masuoka, Kazuhiro</creatorcontrib><creatorcontrib>Kusumi, Eiji</creatorcontrib><creatorcontrib>Kishi, Yukiko</creatorcontrib><creatorcontrib>Matsumura, Tomoko</creatorcontrib><creatorcontrib>Wake, Atsushi</creatorcontrib><creatorcontrib>Morinaga, Shinichi</creatorcontrib><creatorcontrib>Kanda, Yoshinobu</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><title>Graft failure following reduced‐intensity cord blood transplantation for adult patients</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary We reviewed the medical records of 123 adult reduced‐intensity cord blood transplantation (RI‐CBT) recipients to investigate the clinical features of graft failure after RI‐CBT. Nine (7·3%) had graft failure, and were classified as graft rejection rather than primary graft failure; they showed peripheral cytopenia with complete loss of donor‐type haematopoiesis, implying destruction of donor cells by immunological mechanisms rather than poor graft function. Three of them died of bacterial or fungal infection during neutropenia. Two recovered autologous haematopoiesis. The remaining four patients underwent a second RI‐CBT and developed severe regimen‐related toxicities. One died of pneumonia on day 8, and the other three achieved engraftment. Two of them died of transplant‐related mortality, and the other survived without disease progression for 9·0 months after the second RI‐CBT. In total, seven of the nine patients with graft failure died. The median survival of those with graft failure was 3·8 months (range, 0·9–15·4). Graft failure is a serious complication of RI‐CBT. As host T cells cannot completely be eliminated by reduced‐intensity preparative regimens, we need to be aware of the difficulty in differentiating graft rejection from other causes of graft failure following RI‐CBT. Further studies are warranted to establish optimal diagnostic and treatment strategies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>chimaerism</subject><subject>Cord Blood Stem Cell Transplantation - methods</subject><subject>Female</subject><subject>graft failure</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>Graft vs Host Disease - diagnosis</subject><subject>graft‐versus‐host disease</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematologic Neoplasms - complications</subject><subject>Hematologic Neoplasms - therapy</subject><subject>Hematology</subject><subject>Histocompatibility Testing</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutropenia - complications</subject><subject>Opportunistic Infections - complications</subject><subject>second transplantation</subject><subject>Treatment Outcome</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkL1u2zAURokiReOmfYWACJBRyqVISvKQITESJ0WALu3QieCfChm06JAUYm95hD5jn6RUbMRr78IL8nyX5EEIEyhJrqtVSWjNi4owUlYAvATe0qrcfkCz94MTNAOApiDA2lP0OcYVAKHAySd0SmraECDtDP1aBtkl3MnejcHizjvnX_rhNw7WjNqav69_-iHZIfZph7UPBivnvcEpyCFunBySTL0fcjBgaUaX8CZv2CHFL-hjJ120Xw_rGfp5f_dj8VA8fV8-Lm6eCs0ZVIWSVinLqakNo5wzUjNOZWO1MU0tm1rrhtfK2K6iis6V0jb_TVsN1KgWpKZn6GI_dxP882hjEis_hiFfKci85UA4azPU7iEdfIzBdmIT-rUMO0FATErFSkzmxGROTErFm1KxzdHzw_xRra05Bg8OM3B5AGTU0nXZjO7jkWtYU88Zy9z1nnvpnd399wPE7beHqaP_ANANlK8</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>Narimatsu, Hiroto</creator><creator>Kami, Masahiro</creator><creator>Miyakoshi, Shigesaburo</creator><creator>Murashige, Naoko</creator><creator>Yuji, Koichiro</creator><creator>Hamaki, Tamae</creator><creator>Masuoka, Kazuhiro</creator><creator>Kusumi, Eiji</creator><creator>Kishi, Yukiko</creator><creator>Matsumura, Tomoko</creator><creator>Wake, Atsushi</creator><creator>Morinaga, Shinichi</creator><creator>Kanda, Yoshinobu</creator><creator>Taniguchi, Shuichi</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Blackwell Publishing Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200601</creationdate><title>Graft failure following reduced‐intensity cord blood transplantation for adult patients</title><author>Narimatsu, Hiroto ; Kami, Masahiro ; Miyakoshi, Shigesaburo ; Murashige, Naoko ; Yuji, Koichiro ; Hamaki, Tamae ; Masuoka, Kazuhiro ; Kusumi, Eiji ; Kishi, Yukiko ; Matsumura, Tomoko ; Wake, Atsushi ; Morinaga, Shinichi ; Kanda, Yoshinobu ; Taniguchi, Shuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5402-baebbe53d6d4355416453a7ecdd76a76cc756bdef23b39bbce141cec03db80ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>chimaerism</topic><topic>Cord Blood Stem Cell Transplantation - methods</topic><topic>Female</topic><topic>graft failure</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>Graft vs Host Disease - diagnosis</topic><topic>graft‐versus‐host disease</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematologic Neoplasms - complications</topic><topic>Hematologic Neoplasms - therapy</topic><topic>Hematology</topic><topic>Histocompatibility Testing</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutropenia - complications</topic><topic>Opportunistic Infections - complications</topic><topic>second transplantation</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Narimatsu, Hiroto</creatorcontrib><creatorcontrib>Kami, Masahiro</creatorcontrib><creatorcontrib>Miyakoshi, Shigesaburo</creatorcontrib><creatorcontrib>Murashige, Naoko</creatorcontrib><creatorcontrib>Yuji, Koichiro</creatorcontrib><creatorcontrib>Hamaki, Tamae</creatorcontrib><creatorcontrib>Masuoka, Kazuhiro</creatorcontrib><creatorcontrib>Kusumi, Eiji</creatorcontrib><creatorcontrib>Kishi, Yukiko</creatorcontrib><creatorcontrib>Matsumura, Tomoko</creatorcontrib><creatorcontrib>Wake, Atsushi</creatorcontrib><creatorcontrib>Morinaga, Shinichi</creatorcontrib><creatorcontrib>Kanda, Yoshinobu</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Narimatsu, Hiroto</au><au>Kami, Masahiro</au><au>Miyakoshi, Shigesaburo</au><au>Murashige, Naoko</au><au>Yuji, Koichiro</au><au>Hamaki, Tamae</au><au>Masuoka, Kazuhiro</au><au>Kusumi, Eiji</au><au>Kishi, Yukiko</au><au>Matsumura, Tomoko</au><au>Wake, Atsushi</au><au>Morinaga, Shinichi</au><au>Kanda, Yoshinobu</au><au>Taniguchi, Shuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Graft failure following reduced‐intensity cord blood transplantation for adult patients</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2006-01</date><risdate>2006</risdate><volume>132</volume><issue>1</issue><spage>36</spage><epage>41</epage><pages>36-41</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary We reviewed the medical records of 123 adult reduced‐intensity cord blood transplantation (RI‐CBT) recipients to investigate the clinical features of graft failure after RI‐CBT. Nine (7·3%) had graft failure, and were classified as graft rejection rather than primary graft failure; they showed peripheral cytopenia with complete loss of donor‐type haematopoiesis, implying destruction of donor cells by immunological mechanisms rather than poor graft function. Three of them died of bacterial or fungal infection during neutropenia. Two recovered autologous haematopoiesis. The remaining four patients underwent a second RI‐CBT and developed severe regimen‐related toxicities. One died of pneumonia on day 8, and the other three achieved engraftment. Two of them died of transplant‐related mortality, and the other survived without disease progression for 9·0 months after the second RI‐CBT. In total, seven of the nine patients with graft failure died. The median survival of those with graft failure was 3·8 months (range, 0·9–15·4). Graft failure is a serious complication of RI‐CBT. As host T cells cannot completely be eliminated by reduced‐intensity preparative regimens, we need to be aware of the difficulty in differentiating graft rejection from other causes of graft failure following RI‐CBT. Further studies are warranted to establish optimal diagnostic and treatment strategies.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>16371018</pmid><doi>10.1111/j.1365-2141.2005.05832.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2006-01, Vol.132 (1), p.36-41
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_journals_198501548
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection)
subjects Adolescent
Adult
Aged
Biological and medical sciences
chimaerism
Cord Blood Stem Cell Transplantation - methods
Female
graft failure
Graft Rejection
Graft Survival
Graft vs Host Disease - diagnosis
graft‐versus‐host disease
Hematologic and hematopoietic diseases
Hematologic Neoplasms - complications
Hematologic Neoplasms - therapy
Hematology
Histocompatibility Testing
Humans
Male
Medical sciences
Middle Aged
Neutropenia - complications
Opportunistic Infections - complications
second transplantation
Treatment Outcome
title Graft failure following reduced‐intensity cord blood transplantation for adult patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T06%3A50%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Graft%20failure%20following%20reduced%E2%80%90intensity%20cord%20blood%20transplantation%20for%20adult%20patients&rft.jtitle=British%20journal%20of%20haematology&rft.au=Narimatsu,%20Hiroto&rft.date=2006-01&rft.volume=132&rft.issue=1&rft.spage=36&rft.epage=41&rft.pages=36-41&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2005.05832.x&rft_dat=%3Cproquest_cross%3E943886951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198501548&rft_id=info:pmid/16371018&rfr_iscdi=true